Diagnosis and Treatment of Vascular Disease in Women
Women with peripheral artery disease (PAD) are more likely to present without symptoms. As a consequence, their vascular disease has been underdiagnosed and undertreated. As the population ages, the prevalence of PAD will increase significantly. There has been an increased effort to delineate the effects of sex on the clinical burden and risks presented by PAD. Better knowledge of these effects will hopefully result in the development of strategies to achieve sex-specific cardiovascular risk reduction and improvement in overall quality of life for women. Dr. Julie A. Freischlag discusses how to formulate a preventive clinical plan in the management of vascular disease in women.
Cardiologists, Vascular Surgeons, Interventional Radiologists, Interventional Cardiologists, Primary Care Physicians, Podiatrists, Emergency Medicine Physicians, General Internists, and other interested healthcare providers.
- Discuss the risk factors, incidence and prevalence of vascular disease in women.
- Recognize the differences in outcomes in women who undergo medical and/or surgical intervention for their vascular disease.
- Formulate a preventive clinical plan to avert vascular disease in women.
Julie A. Freischlag, M.D., FACS, FRCSEd, DFSVS
Chief Executive Officer, Wake Forest Baptist Medical Center
Dean, Wake Forest School of Medicine
Winston-Salem, North Carolina
Julie A. Freischlag, M.D., faculty of this educational activity, has no relevant financial relationships with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Conference Directors and Planning Committee Members
Cristina Alvarez, Howard Katzman, M.D., Ignacio Rua, M.D., have no relevant financial relationships with ineligible companies* to disclose.
James Benenati, M.D., indicated that he is a consultant for Bard and Penumbra. He also owns stock in Penumbra and Scientia.
Barry T. Katzen, M.D., indicated that he is a consultant for Boston Scientific, Philips Medical, W.L. Gore and Bard Medical.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.